Cagrilintide

Cagrilintide: The "Satiety Sustainer"

Cagrilintide is a long-acting synthetic analogue of Amylin, a hormone naturally co-secreted with insulin by the pancreas. While GLP-1 peptides (like Semaglutide) target the gut-brain axis primarily through incretin receptors, Cagrilintide operates via a completely different pathway, making it a "dual-action" heavyweight for weight management.

Its unique strength is its ability to "stack" with other metabolic peptides to break through weightloss plateaus.

• Amylin Receptor Agonism: It mimics natural amylin to signal the brain’s area postrema (the hunger control center) that the body is full. This creates a more profound sense of satiety than GLP-1s alone.

• Delayed Gastric Emptying: It slows the rate at which food leaves the stomach. This not only keeps you feeling physically full for longer but also smooths out post-meal blood sugar spikes.

• Glucagon Suppression: Like natural amylin, it helps inhibit the over-secretion of glucagon, preventing the liver from dumping unnecessary glucose into the bloodstream.

• Synergistic Potency: When combined with GLP-1 or GIP agonists (the "CagriSema" combination), it targets hunger from two different directions, often resulting in significantly higher weight loss percentages in clinical trials compared to single-agent therapies. Essentially, if your GLP is the volume knob that turns down hunger, Cagrilintide is the "off switch" that helps you feel finished with a meal much sooner and stay satisfied much longer.

RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION